Herborium Group, Inc.
Get $10 bonus on your first $100 deposit for HBRM
Get $10 bonus on your first $100 deposit for HBRM
Herborium Group, Inc. (HBRM) Stock Competitors & Peer Comparison
See (HBRM) competitors and their performances in Stock Market.
Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry
Detailed financial metrics including price, market cap, P/E ratio, and more.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| HBRM | $0.00 | +9900.00% | 1.1M | N/A | N/A | N/A |
| IPSEY | $48.55 | -1.22% | 64.2B | 30.92 | $1.57 | +0.82% |
| MKKGY | $27.80 | +2.96% | 60.5B | 19.73 | $1.41 | +1.78% |
| MKGAF | $138.51 | +0.43% | 59.2B | 19.23 | $7.08 | +1.84% |
| TKPHF | $34.52 | +0.00% | 54.5B | 76.71 | $0.45 | +3.77% |
| HLNCF | $4.82 | +1.05% | 42.9B | 19.26 | $0.25 | +2.05% |
| SDZNY | $85.78 | +2.66% | 37.2B | 41.12 | $2.09 | +0.72% |
| TEVJF | $28.36 | +0.00% | 33B | 23.44 | $1.21 | N/A |
| SGIOF | $19.10 | -12.59% | 18.6B | 17.20 | $1.27 | +2.04% |
| TAIPY | $14.00 | +16.67% | 18.1B | 82.35 | $0.17 | N/A |
Stock Comparison
HBRM vs IPSEY Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, IPSEY has a market cap of 64.2B. Regarding current trading prices, HBRM is priced at $0.00, while IPSEY trades at $48.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas IPSEY's P/E ratio is 30.92. In terms of profitability, HBRM's ROE is +0.04%, compared to IPSEY's ROE of +0.10%. Regarding short-term risk, HBRM is more volatile compared to IPSEY. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check IPSEY's competition here
HBRM vs MKKGY Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, MKKGY has a market cap of 60.5B. Regarding current trading prices, HBRM is priced at $0.00, while MKKGY trades at $27.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas MKKGY's P/E ratio is 19.73. In terms of profitability, HBRM's ROE is +0.04%, compared to MKKGY's ROE of +0.09%. Regarding short-term risk, HBRM is more volatile compared to MKKGY. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check MKKGY's competition here
HBRM vs MKGAF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, MKGAF has a market cap of 59.2B. Regarding current trading prices, HBRM is priced at $0.00, while MKGAF trades at $138.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas MKGAF's P/E ratio is 19.23. In terms of profitability, HBRM's ROE is +0.04%, compared to MKGAF's ROE of +0.09%. Regarding short-term risk, HBRM is more volatile compared to MKGAF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check MKGAF's competition here
HBRM vs TKPHF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, TKPHF has a market cap of 54.5B. Regarding current trading prices, HBRM is priced at $0.00, while TKPHF trades at $34.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas TKPHF's P/E ratio is 76.71. In terms of profitability, HBRM's ROE is +0.04%, compared to TKPHF's ROE of +0.02%. Regarding short-term risk, HBRM is more volatile compared to TKPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check TKPHF's competition here
HBRM vs HLNCF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, HLNCF has a market cap of 42.9B. Regarding current trading prices, HBRM is priced at $0.00, while HLNCF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas HLNCF's P/E ratio is 19.26. In terms of profitability, HBRM's ROE is +0.04%, compared to HLNCF's ROE of +0.06%. Regarding short-term risk, HBRM is more volatile compared to HLNCF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check HLNCF's competition here
HBRM vs SDZNY Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, SDZNY has a market cap of 37.2B. Regarding current trading prices, HBRM is priced at $0.00, while SDZNY trades at $85.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas SDZNY's P/E ratio is 41.12. In terms of profitability, HBRM's ROE is +0.04%, compared to SDZNY's ROE of +0.08%. Regarding short-term risk, HBRM is more volatile compared to SDZNY. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check SDZNY's competition here
HBRM vs TEVJF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, TEVJF has a market cap of 33B. Regarding current trading prices, HBRM is priced at $0.00, while TEVJF trades at $28.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas TEVJF's P/E ratio is 23.44. In terms of profitability, HBRM's ROE is +0.04%, compared to TEVJF's ROE of +0.20%. Regarding short-term risk, HBRM is more volatile compared to TEVJF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check TEVJF's competition here
HBRM vs SGIOF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, SGIOF has a market cap of 18.6B. Regarding current trading prices, HBRM is priced at $0.00, while SGIOF trades at $19.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas SGIOF's P/E ratio is 17.20. In terms of profitability, HBRM's ROE is +0.04%, compared to SGIOF's ROE of +0.14%. Regarding short-term risk, HBRM is more volatile compared to SGIOF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check SGIOF's competition here
HBRM vs TAIPY Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, TAIPY has a market cap of 18.1B. Regarding current trading prices, HBRM is priced at $0.00, while TAIPY trades at $14.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas TAIPY's P/E ratio is 82.35. In terms of profitability, HBRM's ROE is +0.04%, compared to TAIPY's ROE of +0.02%. Regarding short-term risk, HBRM is more volatile compared to TAIPY. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check TAIPY's competition here
HBRM vs ESALY Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, ESALY has a market cap of 17.6B. Regarding current trading prices, HBRM is priced at $0.00, while ESALY trades at $61.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas ESALY's P/E ratio is 20.54. In terms of profitability, HBRM's ROE is +0.04%, compared to ESALY's ROE of +0.06%. Regarding short-term risk, HBRM is more volatile compared to ESALY. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check ESALY's competition here
HBRM vs SGIOY Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, SGIOY has a market cap of 17.4B. Regarding current trading prices, HBRM is priced at $0.00, while SGIOY trades at $10.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas SGIOY's P/E ratio is 16.27. In terms of profitability, HBRM's ROE is +0.04%, compared to SGIOY's ROE of +0.14%. Regarding short-term risk, HBRM is more volatile compared to SGIOY. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check SGIOY's competition here
HBRM vs BIOVF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, BIOVF has a market cap of 13.8B. Regarding current trading prices, HBRM is priced at $0.00, while BIOVF trades at $39.87.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas BIOVF's P/E ratio is 265.80. In terms of profitability, HBRM's ROE is +0.04%, compared to BIOVF's ROE of +0.01%. Regarding short-term risk, HBRM is more volatile compared to BIOVF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check BIOVF's competition here
HBRM vs IPSEF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, IPSEF has a market cap of 9.4B. Regarding current trading prices, HBRM is priced at $0.00, while IPSEF trades at $113.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas IPSEF's P/E ratio is 18.07. In terms of profitability, HBRM's ROE is +0.04%, compared to IPSEF's ROE of +0.12%. Regarding short-term risk, HBRM is more volatile compared to IPSEF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check IPSEF's competition here
HBRM vs ESAIY Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, ESAIY has a market cap of 8.8B. Regarding current trading prices, HBRM is priced at $0.00, while ESAIY trades at $7.74.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas ESAIY's P/E ratio is 27.58. In terms of profitability, HBRM's ROE is +0.04%, compared to ESAIY's ROE of +0.05%. Regarding short-term risk, HBRM is more volatile compared to ESAIY. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check ESAIY's competition here
HBRM vs ESALF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, ESALF has a market cap of 8.5B. Regarding current trading prices, HBRM is priced at $0.00, while ESALF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas ESALF's P/E ratio is 27.27. In terms of profitability, HBRM's ROE is +0.04%, compared to ESALF's ROE of +0.05%. Regarding short-term risk, HBRM is more volatile compared to ESALF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check ESALF's competition here
HBRM vs SFOSF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, SFOSF has a market cap of 7.1B. Regarding current trading prices, HBRM is priced at $0.00, while SFOSF trades at $2.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas SFOSF's P/E ratio is 14.21. In terms of profitability, HBRM's ROE is +0.04%, compared to SFOSF's ROE of +0.09%. Regarding short-term risk, HBRM is more volatile compared to SFOSF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check SFOSF's competition here
HBRM vs GZPHF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, GZPHF has a market cap of 6.2B. Regarding current trading prices, HBRM is priced at $0.00, while GZPHF trades at $2.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas GZPHF's P/E ratio is 9.00. In terms of profitability, HBRM's ROE is +0.04%, compared to GZPHF's ROE of +0.08%. Regarding short-term risk, HBRM is more volatile compared to GZPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check GZPHF's competition here
HBRM vs LVZPF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, LVZPF has a market cap of 6.1B. Regarding current trading prices, HBRM is priced at $0.00, while LVZPF trades at $5.22.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas LVZPF's P/E ratio is 15.35. In terms of profitability, HBRM's ROE is +0.04%, compared to LVZPF's ROE of +0.15%. Regarding short-term risk, HBRM is more volatile compared to LVZPF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check LVZPF's competition here
HBRM vs HLUBF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, HLUBF has a market cap of 4.8B. Regarding current trading prices, HBRM is priced at $0.00, while HLUBF trades at $4.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas HLUBF's P/E ratio is 9.45. In terms of profitability, HBRM's ROE is +0.04%, compared to HLUBF's ROE of +0.13%. Regarding short-term risk, HBRM is more volatile compared to HLUBF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check HLUBF's competition here
HBRM vs HLBBF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, HLBBF has a market cap of 4.7B. Regarding current trading prices, HBRM is priced at $0.00, while HLBBF trades at $5.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas HLBBF's P/E ratio is 11.57. In terms of profitability, HBRM's ROE is +0.04%, compared to HLBBF's ROE of +0.13%. Regarding short-term risk, HBRM is more volatile compared to HLBBF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check HLBBF's competition here
HBRM vs SMDPY Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, SMDPY has a market cap of 4.7B. Regarding current trading prices, HBRM is priced at $0.00, while SMDPY trades at $11.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas SMDPY's P/E ratio is 4.80. In terms of profitability, HBRM's ROE is +0.04%, compared to SMDPY's ROE of +0.49%. Regarding short-term risk, HBRM is more volatile compared to SMDPY. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check SMDPY's competition here
HBRM vs DNPUF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, DNPUF has a market cap of 4.4B. Regarding current trading prices, HBRM is priced at $0.00, while DNPUF trades at $11.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas DNPUF's P/E ratio is 4.53. In terms of profitability, HBRM's ROE is +0.04%, compared to DNPUF's ROE of +0.49%. Regarding short-term risk, HBRM is more volatile compared to DNPUF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check DNPUF's competition here
HBRM vs SGFEF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, SGFEF has a market cap of 4.4B. Regarding current trading prices, HBRM is priced at $0.00, while SGFEF trades at $100.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas SGFEF's P/E ratio is 20.62. In terms of profitability, HBRM's ROE is +0.04%, compared to SGFEF's ROE of +0.16%. Regarding short-term risk, HBRM is less volatile compared to SGFEF. This indicates potentially lower risk in terms of short-term price fluctuations for HBRM.Check SGFEF's competition here
HBRM vs HKMPY Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, HKMPY has a market cap of 4.1B. Regarding current trading prices, HBRM is priced at $0.00, while HKMPY trades at $37.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas HKMPY's P/E ratio is 10.24. In terms of profitability, HBRM's ROE is +0.04%, compared to HKMPY's ROE of +0.16%. Regarding short-term risk, HBRM is more volatile compared to HKMPY. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check HKMPY's competition here
HBRM vs HKMPF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, HKMPF has a market cap of 4B. Regarding current trading prices, HBRM is priced at $0.00, while HKMPF trades at $18.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas HKMPF's P/E ratio is 10.34. In terms of profitability, HBRM's ROE is +0.04%, compared to HKMPF's ROE of +0.16%. Regarding short-term risk, HBRM is more volatile compared to HKMPF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check HKMPF's competition here
HBRM vs APNHF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, APNHF has a market cap of 3.9B. Regarding current trading prices, HBRM is priced at $0.00, while APNHF trades at $8.69.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas APNHF's P/E ratio is -34.76. In terms of profitability, HBRM's ROE is +0.04%, compared to APNHF's ROE of -0.02%. Regarding short-term risk, HBRM is more volatile compared to APNHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check APNHF's competition here
HBRM vs APNHY Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, APNHY has a market cap of 3.6B. Regarding current trading prices, HBRM is priced at $0.00, while APNHY trades at $8.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas APNHY's P/E ratio is -32.00. In terms of profitability, HBRM's ROE is +0.04%, compared to APNHY's ROE of -0.02%. Regarding short-term risk, HBRM is more volatile compared to APNHY. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check APNHY's competition here
HBRM vs HYPMY Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, HYPMY has a market cap of 3.4B. Regarding current trading prices, HBRM is priced at $0.00, while HYPMY trades at $4.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas HYPMY's P/E ratio is 12.91. In terms of profitability, HBRM's ROE is +0.04%, compared to HYPMY's ROE of +0.10%. Regarding short-term risk, HBRM is more volatile compared to HYPMY. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check HYPMY's competition here
HBRM vs LBTSF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, LBTSF has a market cap of 3.3B. Regarding current trading prices, HBRM is priced at $0.00, while LBTSF trades at $15.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas LBTSF's P/E ratio is 59.04. In terms of profitability, HBRM's ROE is +0.04%, compared to LBTSF's ROE of +0.04%. Regarding short-term risk, HBRM is more volatile compared to LBTSF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check LBTSF's competition here
HBRM vs CHSYF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, CHSYF has a market cap of 3.3B. Regarding current trading prices, HBRM is priced at $0.00, while CHSYF trades at $1.35.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas CHSYF's P/E ratio is 13.50. In terms of profitability, HBRM's ROE is +0.04%, compared to CHSYF's ROE of +0.09%. Regarding short-term risk, HBRM is more volatile compared to CHSYF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check CHSYF's competition here
HBRM vs INVVY Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, INVVY has a market cap of 3B. Regarding current trading prices, HBRM is priced at $0.00, while INVVY trades at $21.85.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas INVVY's P/E ratio is -62.42. In terms of profitability, HBRM's ROE is +0.04%, compared to INVVY's ROE of -0.99%. Regarding short-term risk, HBRM is more volatile compared to INVVY. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check INVVY's competition here
HBRM vs IZQVF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, IZQVF has a market cap of 2.9B. Regarding current trading prices, HBRM is priced at $0.00, while IZQVF trades at $20.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas IZQVF's P/E ratio is -56.68. In terms of profitability, HBRM's ROE is +0.04%, compared to IZQVF's ROE of -0.99%. Regarding short-term risk, HBRM is more volatile compared to IZQVF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check IZQVF's competition here
HBRM vs ULIHF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, ULIHF has a market cap of 2.6B. Regarding current trading prices, HBRM is priced at $0.00, while ULIHF trades at $1.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas ULIHF's P/E ratio is 8.25. In terms of profitability, HBRM's ROE is +0.04%, compared to ULIHF's ROE of +0.13%. Regarding short-term risk, HBRM is more volatile compared to ULIHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check ULIHF's competition here
HBRM vs HMDCF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, HMDCF has a market cap of 2.4B. Regarding current trading prices, HBRM is priced at $0.00, while HMDCF trades at $2.82.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas HMDCF's P/E ratio is 5.32. In terms of profitability, HBRM's ROE is +0.04%, compared to HMDCF's ROE of +0.41%. Regarding short-term risk, HBRM is more volatile compared to HMDCF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check HMDCF's competition here
HBRM vs NPPNY Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, NPPNY has a market cap of 2.2B. Regarding current trading prices, HBRM is priced at $0.00, while NPPNY trades at $8.15.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas NPPNY's P/E ratio is 10.87. In terms of profitability, HBRM's ROE is +0.04%, compared to NPPNY's ROE of +0.12%. Regarding short-term risk, HBRM is more volatile compared to NPPNY. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check NPPNY's competition here
HBRM vs DMPHF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, DMPHF has a market cap of 2.1B. Regarding current trading prices, HBRM is priced at $0.00, while DMPHF trades at $39.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas DMPHF's P/E ratio is 17.90. In terms of profitability, HBRM's ROE is +0.04%, compared to DMPHF's ROE of +0.20%. Regarding short-term risk, HBRM is more volatile compared to DMPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check DMPHF's competition here
HBRM vs NPNKF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, NPNKF has a market cap of 2.1B. Regarding current trading prices, HBRM is priced at $0.00, while NPNKF trades at $31.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas NPNKF's P/E ratio is 10.50. In terms of profitability, HBRM's ROE is +0.04%, compared to NPNKF's ROE of +0.11%. Regarding short-term risk, HBRM is more volatile compared to NPNKF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check NPNKF's competition here
HBRM vs CURLF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, CURLF has a market cap of 2.1B. Regarding current trading prices, HBRM is priced at $0.00, while CURLF trades at $2.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas CURLF's P/E ratio is -8.48. In terms of profitability, HBRM's ROE is +0.04%, compared to CURLF's ROE of -0.29%. Regarding short-term risk, HBRM is more volatile compared to CURLF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check CURLF's competition here
HBRM vs HTSUF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, HTSUF has a market cap of 2B. Regarding current trading prices, HBRM is priced at $0.00, while HTSUF trades at $29.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas HTSUF's P/E ratio is 16.76. In terms of profitability, HBRM's ROE is +0.04%, compared to HTSUF's ROE of +0.07%. Regarding short-term risk, HBRM is more volatile compared to HTSUF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check HTSUF's competition here
HBRM vs ARSUF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, ARSUF has a market cap of 1.9B. Regarding current trading prices, HBRM is priced at $0.00, while ARSUF trades at $26.53.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas ARSUF's P/E ratio is 18.30. In terms of profitability, HBRM's ROE is +0.04%, compared to ARSUF's ROE of +0.17%. Regarding short-term risk, HBRM is more volatile compared to ARSUF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check ARSUF's competition here
HBRM vs DUTV Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, DUTV has a market cap of 1.9B. Regarding current trading prices, HBRM is priced at $0.00, while DUTV trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas DUTV's P/E ratio is N/A. In terms of profitability, HBRM's ROE is +0.04%, compared to DUTV's ROE of -0.04%. Regarding short-term risk, HBRM is more volatile compared to DUTV. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check DUTV's competition here
HBRM vs TSMRF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, TSMRF has a market cap of 1.7B. Regarding current trading prices, HBRM is priced at $0.00, while TSMRF trades at $23.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas TSMRF's P/E ratio is 10.04. In terms of profitability, HBRM's ROE is +0.04%, compared to TSMRF's ROE of +0.10%. Regarding short-term risk, HBRM is more volatile compared to TSMRF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check TSMRF's competition here
HBRM vs SHPHF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, SHPHF has a market cap of 1.7B. Regarding current trading prices, HBRM is priced at $0.00, while SHPHF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas SHPHF's P/E ratio is -6.22. In terms of profitability, HBRM's ROE is +0.04%, compared to SHPHF's ROE of +0.03%. Regarding short-term risk, HBRM is more volatile compared to SHPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check SHPHF's competition here
HBRM vs GTBIF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, GTBIF has a market cap of 1.6B. Regarding current trading prices, HBRM is priced at $0.00, while GTBIF trades at $6.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas GTBIF's P/E ratio is 14.06. In terms of profitability, HBRM's ROE is +0.04%, compared to GTBIF's ROE of +0.06%. Regarding short-term risk, HBRM is more volatile compared to GTBIF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check GTBIF's competition here
HBRM vs MITPF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, MITPF has a market cap of 1.6B. Regarding current trading prices, HBRM is priced at $0.00, while MITPF trades at $23.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas MITPF's P/E ratio is -10.81. In terms of profitability, HBRM's ROE is +0.04%, compared to MITPF's ROE of +4.99%. Regarding short-term risk, HBRM is less volatile compared to MITPF. This indicates potentially lower risk in terms of short-term price fluctuations for HBRM.Check MITPF's competition here
HBRM vs KARBF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, KARBF has a market cap of 1.5B. Regarding current trading prices, HBRM is priced at $0.00, while KARBF trades at $5.25.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas KARBF's P/E ratio is 262.50. In terms of profitability, HBRM's ROE is +0.04%, compared to KARBF's ROE of N/A. Regarding short-term risk, HBRM is more volatile compared to KARBF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check KARBF's competition here
HBRM vs CHIZF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, CHIZF has a market cap of 1.4B. Regarding current trading prices, HBRM is priced at $0.00, while CHIZF trades at $0.27.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas CHIZF's P/E ratio is -27.34. In terms of profitability, HBRM's ROE is +0.04%, compared to CHIZF's ROE of -0.01%. Regarding short-term risk, HBRM is more volatile compared to CHIZF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check CHIZF's competition here
HBRM vs CASBF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, CASBF has a market cap of 1.3B. Regarding current trading prices, HBRM is priced at $0.00, while CASBF trades at $3.86.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas CASBF's P/E ratio is -38.60. In terms of profitability, HBRM's ROE is +0.04%, compared to CASBF's ROE of +0.01%. Regarding short-term risk, HBRM is more volatile compared to CASBF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check CASBF's competition here
HBRM vs SWGHF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, SWGHF has a market cap of 1.3B. Regarding current trading prices, HBRM is priced at $0.00, while SWGHF trades at $11.52.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas SWGHF's P/E ratio is 15.57. In terms of profitability, HBRM's ROE is +0.04%, compared to SWGHF's ROE of +0.05%. Regarding short-term risk, HBRM is more volatile compared to SWGHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check SWGHF's competition here
HBRM vs TCNNF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, TCNNF has a market cap of 1.2B. Regarding current trading prices, HBRM is priced at $0.00, while TCNNF trades at $6.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas TCNNF's P/E ratio is -10.88. In terms of profitability, HBRM's ROE is +0.04%, compared to TCNNF's ROE of -0.10%. Regarding short-term risk, HBRM is more volatile compared to TCNNF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check TCNNF's competition here
HBRM vs LJUIF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, LJUIF has a market cap of 1.2B. Regarding current trading prices, HBRM is priced at $0.00, while LJUIF trades at $0.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas LJUIF's P/E ratio is 13.42. In terms of profitability, HBRM's ROE is +0.04%, compared to LJUIF's ROE of +0.06%. Regarding short-term risk, HBRM is more volatile compared to LJUIF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check LJUIF's competition here
HBRM vs BIOGY Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, BIOGY has a market cap of 1.1B. Regarding current trading prices, HBRM is priced at $0.00, while BIOGY trades at $11.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas BIOGY's P/E ratio is 31.43. In terms of profitability, HBRM's ROE is +0.04%, compared to BIOGY's ROE of +0.24%. Regarding short-term risk, HBRM is more volatile compared to BIOGY. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check BIOGY's competition here
HBRM vs KSPHF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, KSPHF has a market cap of 1.1B. Regarding current trading prices, HBRM is priced at $0.00, while KSPHF trades at $25.77.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas KSPHF's P/E ratio is 11.93. In terms of profitability, HBRM's ROE is +0.04%, compared to KSPHF's ROE of +0.07%. Regarding short-term risk, HBRM is more volatile compared to KSPHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check KSPHF's competition here
HBRM vs GNMLF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, GNMLF has a market cap of 1.1B. Regarding current trading prices, HBRM is priced at $0.00, while GNMLF trades at $1.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas GNMLF's P/E ratio is 12.00. In terms of profitability, HBRM's ROE is +0.04%, compared to GNMLF's ROE of +0.11%. Regarding short-term risk, HBRM is more volatile compared to GNMLF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check GNMLF's competition here
HBRM vs KKPCF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, KKPCF has a market cap of 984.6M. Regarding current trading prices, HBRM is priced at $0.00, while KKPCF trades at $26.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas KKPCF's P/E ratio is 288.89. In terms of profitability, HBRM's ROE is +0.04%, compared to KKPCF's ROE of -0.03%. Regarding short-term risk, HBRM is more volatile compared to KKPCF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check KKPCF's competition here
HBRM vs EVOTF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, EVOTF has a market cap of 930.6M. Regarding current trading prices, HBRM is priced at $0.00, while EVOTF trades at $5.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas EVOTF's P/E ratio is -7.71. In terms of profitability, HBRM's ROE is +0.04%, compared to EVOTF's ROE of -0.12%. Regarding short-term risk, HBRM is more volatile compared to EVOTF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check EVOTF's competition here
HBRM vs TWAPF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, TWAPF has a market cap of 828.5M. Regarding current trading prices, HBRM is priced at $0.00, while TWAPF trades at $16.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas TWAPF's P/E ratio is 6.28. In terms of profitability, HBRM's ROE is +0.04%, compared to TWAPF's ROE of +0.12%. Regarding short-term risk, HBRM is more volatile compared to TWAPF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check TWAPF's competition here
HBRM vs NIKA Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, NIKA has a market cap of 764.5M. Regarding current trading prices, HBRM is priced at $0.00, while NIKA trades at $0.73.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas NIKA's P/E ratio is N/A. In terms of profitability, HBRM's ROE is +0.04%, compared to NIKA's ROE of +0.29%. Regarding short-term risk, HBRM is more volatile compared to NIKA. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check NIKA's competition here
HBRM vs CSWYF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, CSWYF has a market cap of 758.4M. Regarding current trading prices, HBRM is priced at $0.00, while CSWYF trades at $1.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas CSWYF's P/E ratio is 4.78. In terms of profitability, HBRM's ROE is +0.04%, compared to CSWYF's ROE of +0.20%. Regarding short-term risk, HBRM is more volatile compared to CSWYF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check CSWYF's competition here
HBRM vs TRXPF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, TRXPF has a market cap of 690.7M. Regarding current trading prices, HBRM is priced at $0.00, while TRXPF trades at $24.57.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas TRXPF's P/E ratio is 25.86. In terms of profitability, HBRM's ROE is +0.04%, compared to TRXPF's ROE of +0.03%. Regarding short-term risk, HBRM is more volatile compared to TRXPF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check TRXPF's competition here
HBRM vs SHEZF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, SHEZF has a market cap of 689M. Regarding current trading prices, HBRM is priced at $0.00, while SHEZF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas SHEZF's P/E ratio is -23.48. In terms of profitability, HBRM's ROE is +0.04%, compared to SHEZF's ROE of +0.01%. Regarding short-term risk, HBRM is more volatile compared to SHEZF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check SHEZF's competition here
HBRM vs YIHCF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, YIHCF has a market cap of 643.1M. Regarding current trading prices, HBRM is priced at $0.00, while YIHCF trades at $0.55.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas YIHCF's P/E ratio is -5.00. In terms of profitability, HBRM's ROE is +0.04%, compared to YIHCF's ROE of +0.06%. Regarding short-term risk, HBRM is more volatile compared to YIHCF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check YIHCF's competition here
HBRM vs GLASF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, GLASF has a market cap of 643.1M. Regarding current trading prices, HBRM is priced at $0.00, while GLASF trades at $8.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas GLASF's P/E ratio is -15.10. In terms of profitability, HBRM's ROE is +0.04%, compared to GLASF's ROE of -0.23%. Regarding short-term risk, HBRM is more volatile compared to GLASF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check GLASF's competition here
HBRM vs AIHLF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, AIHLF has a market cap of 624.3M. Regarding current trading prices, HBRM is priced at $0.00, while AIHLF trades at $3.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas AIHLF's P/E ratio is 10.94. In terms of profitability, HBRM's ROE is +0.04%, compared to AIHLF's ROE of +0.15%. Regarding short-term risk, HBRM is more volatile compared to AIHLF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check AIHLF's competition here
HBRM vs TRSSF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, TRSSF has a market cap of 601.9M. Regarding current trading prices, HBRM is priced at $0.00, while TRSSF trades at $1.72.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas TRSSF's P/E ratio is -1.32. In terms of profitability, HBRM's ROE is +0.04%, compared to TRSSF's ROE of -0.68%. Regarding short-term risk, HBRM is more volatile compared to TRSSF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check TRSSF's competition here
HBRM vs AGYTF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, AGYTF has a market cap of 554.6M. Regarding current trading prices, HBRM is priced at $0.00, while AGYTF trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas AGYTF's P/E ratio is -11.00. In terms of profitability, HBRM's ROE is +0.04%, compared to AGYTF's ROE of +2.84%. Regarding short-term risk, HBRM is more volatile compared to AGYTF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check AGYTF's competition here
HBRM vs PKBFF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, PKBFF has a market cap of 544.7M. Regarding current trading prices, HBRM is priced at $0.00, while PKBFF trades at $0.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas PKBFF's P/E ratio is N/A. In terms of profitability, HBRM's ROE is +0.04%, compared to PKBFF's ROE of +7.96%. Regarding short-term risk, HBRM is more volatile compared to PKBFF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check PKBFF's competition here
HBRM vs KHTRF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, KHTRF has a market cap of 538.6M. Regarding current trading prices, HBRM is priced at $0.00, while KHTRF trades at $5.49.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas KHTRF's P/E ratio is -137.35. In terms of profitability, HBRM's ROE is +0.04%, compared to KHTRF's ROE of -0.01%. Regarding short-term risk, HBRM is more volatile compared to KHTRF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check KHTRF's competition here
HBRM vs CCHWF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, CCHWF has a market cap of 521.3M. Regarding current trading prices, HBRM is priced at $0.00, while CCHWF trades at $0.94.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas CCHWF's P/E ratio is -1.12. In terms of profitability, HBRM's ROE is +0.04%, compared to CCHWF's ROE of +0.42%. Regarding short-term risk, HBRM is more volatile compared to CCHWF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check CCHWF's competition here
HBRM vs BOIRF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, BOIRF has a market cap of 520.9M. Regarding current trading prices, HBRM is priced at $0.00, while BOIRF trades at $30.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas BOIRF's P/E ratio is 22.73. In terms of profitability, HBRM's ROE is +0.04%, compared to BOIRF's ROE of +0.05%. Regarding short-term risk, HBRM is more volatile compared to BOIRF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check BOIRF's competition here
HBRM vs VRNOF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, VRNOF has a market cap of 470.4M. Regarding current trading prices, HBRM is priced at $0.00, while VRNOF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas VRNOF's P/E ratio is -1.31. In terms of profitability, HBRM's ROE is +0.04%, compared to VRNOF's ROE of -0.30%. Regarding short-term risk, HBRM is more volatile compared to VRNOF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check VRNOF's competition here
HBRM vs HUMDF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, HUMDF has a market cap of 466.1M. Regarding current trading prices, HBRM is priced at $0.00, while HUMDF trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas HUMDF's P/E ratio is 2.95. In terms of profitability, HBRM's ROE is +0.04%, compared to HUMDF's ROE of +1.07%. Regarding short-term risk, HBRM is more volatile compared to HUMDF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check HUMDF's competition here
HBRM vs PEXXF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, PEXXF has a market cap of 463.1M. Regarding current trading prices, HBRM is priced at $0.00, while PEXXF trades at $0.09.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas PEXXF's P/E ratio is 9.00. In terms of profitability, HBRM's ROE is +0.04%, compared to PEXXF's ROE of N/A. Regarding short-term risk, HBRM is more volatile compared to PEXXF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check PEXXF's competition here
HBRM vs ELTP Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, ELTP has a market cap of 407.1M. Regarding current trading prices, HBRM is priced at $0.00, while ELTP trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas ELTP's P/E ratio is 9.45. In terms of profitability, HBRM's ROE is +0.04%, compared to ELTP's ROE of +0.71%. Regarding short-term risk, HBRM is more volatile compared to ELTP. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check ELTP's competition here
HBRM vs SWDCF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, SWDCF has a market cap of 399.6M. Regarding current trading prices, HBRM is priced at $0.00, while SWDCF trades at $2.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas SWDCF's P/E ratio is 62.50. In terms of profitability, HBRM's ROE is +0.04%, compared to SWDCF's ROE of +0.01%. Regarding short-term risk, HBRM is more volatile compared to SWDCF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check SWDCF's competition here
HBRM vs CPHRF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, CPHRF has a market cap of 339.7M. Regarding current trading prices, HBRM is priced at $0.00, while CPHRF trades at $13.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas CPHRF's P/E ratio is 12.73. In terms of profitability, HBRM's ROE is +0.04%, compared to CPHRF's ROE of +0.24%. Regarding short-term risk, HBRM is more volatile compared to CPHRF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check CPHRF's competition here
HBRM vs CRLBF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, CRLBF has a market cap of 315.8M. Regarding current trading prices, HBRM is priced at $0.00, while CRLBF trades at $0.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas CRLBF's P/E ratio is -2.42. In terms of profitability, HBRM's ROE is +0.04%, compared to CRLBF's ROE of -0.33%. Regarding short-term risk, HBRM is more volatile compared to CRLBF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check CRLBF's competition here
HBRM vs BHCCF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, BHCCF has a market cap of 225.1M. Regarding current trading prices, HBRM is priced at $0.00, while BHCCF trades at $0.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas BHCCF's P/E ratio is -4.57. In terms of profitability, HBRM's ROE is +0.04%, compared to BHCCF's ROE of +0.29%. Regarding short-term risk, HBRM is more volatile compared to BHCCF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check BHCCF's competition here
HBRM vs PLNHF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, PLNHF has a market cap of 202M. Regarding current trading prices, HBRM is priced at $0.00, while PLNHF trades at $0.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas PLNHF's P/E ratio is -3.50. In terms of profitability, HBRM's ROE is +0.04%, compared to PLNHF's ROE of +659479.06%. Regarding short-term risk, HBRM is more volatile compared to PLNHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check PLNHF's competition here
HBRM vs PHCUF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, PHCUF has a market cap of 188.1M. Regarding current trading prices, HBRM is priced at $0.00, while PHCUF trades at $7.07.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas PHCUF's P/E ratio is -707.00. In terms of profitability, HBRM's ROE is +0.04%, compared to PHCUF's ROE of -0.00%. Regarding short-term risk, HBRM is more volatile compared to PHCUF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check PHCUF's competition here
HBRM vs CBWTF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, CBWTF has a market cap of 145.7M. Regarding current trading prices, HBRM is priced at $0.00, while CBWTF trades at $0.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas CBWTF's P/E ratio is 5.19. In terms of profitability, HBRM's ROE is +0.04%, compared to CBWTF's ROE of +0.23%. Regarding short-term risk, HBRM is more volatile compared to CBWTF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check CBWTF's competition here
HBRM vs SHIEF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, SHIEF has a market cap of 134.6M. Regarding current trading prices, HBRM is priced at $0.00, while SHIEF trades at $0.13.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas SHIEF's P/E ratio is -6.30. In terms of profitability, HBRM's ROE is +0.04%, compared to SHIEF's ROE of +1.01%. Regarding short-term risk, HBRM is more volatile compared to SHIEF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check SHIEF's competition here
HBRM vs COPHF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, COPHF has a market cap of 131.7M. Regarding current trading prices, HBRM is priced at $0.00, while COPHF trades at $0.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas COPHF's P/E ratio is -0.02. In terms of profitability, HBRM's ROE is +0.04%, compared to COPHF's ROE of -5.75%. Regarding short-term risk, HBRM is less volatile compared to COPHF. This indicates potentially lower risk in terms of short-term price fluctuations for HBRM.Check COPHF's competition here
HBRM vs LOVFF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, LOVFF has a market cap of 128.4M. Regarding current trading prices, HBRM is priced at $0.00, while LOVFF trades at $1.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas LOVFF's P/E ratio is 16.25. In terms of profitability, HBRM's ROE is +0.04%, compared to LOVFF's ROE of +0.09%. Regarding short-term risk, HBRM is more volatile compared to LOVFF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check LOVFF's competition here
HBRM vs NWPN Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, NWPN has a market cap of 123.7M. Regarding current trading prices, HBRM is priced at $0.00, while NWPN trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas NWPN's P/E ratio is -0.04. In terms of profitability, HBRM's ROE is +0.04%, compared to NWPN's ROE of +0.13%. Regarding short-term risk, HBRM is less volatile compared to NWPN. This indicates potentially lower risk in terms of short-term price fluctuations for HBRM.Check NWPN's competition here
HBRM vs BIOYF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, BIOYF has a market cap of 123M. Regarding current trading prices, HBRM is priced at $0.00, while BIOYF trades at $10.70.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas BIOYF's P/E ratio is 18.77. In terms of profitability, HBRM's ROE is +0.04%, compared to BIOYF's ROE of +0.23%. Regarding short-term risk, HBRM is more volatile compared to BIOYF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check BIOYF's competition here
HBRM vs LPCUF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, LPCUF has a market cap of 112.1M. Regarding current trading prices, HBRM is priced at $0.00, while LPCUF trades at $0.19.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas LPCUF's P/E ratio is 9.51. In terms of profitability, HBRM's ROE is +0.04%, compared to LPCUF's ROE of +0.06%. Regarding short-term risk, HBRM is more volatile compared to LPCUF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check LPCUF's competition here
HBRM vs CNVCF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, CNVCF has a market cap of 109.2M. Regarding current trading prices, HBRM is priced at $0.00, while CNVCF trades at $6.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas CNVCF's P/E ratio is -5.00. In terms of profitability, HBRM's ROE is +0.04%, compared to CNVCF's ROE of +1.21%. Regarding short-term risk, HBRM is more volatile compared to CNVCF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check CNVCF's competition here
HBRM vs HLTRF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, HLTRF has a market cap of 105.7M. Regarding current trading prices, HBRM is priced at $0.00, while HLTRF trades at $3.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas HLTRF's P/E ratio is -8.67. In terms of profitability, HBRM's ROE is +0.04%, compared to HLTRF's ROE of -0.19%. Regarding short-term risk, HBRM is more volatile compared to HLTRF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check HLTRF's competition here
HBRM vs JUSHF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, JUSHF has a market cap of 101.8M. Regarding current trading prices, HBRM is priced at $0.00, while JUSHF trades at $0.51.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas JUSHF's P/E ratio is -1.46. In terms of profitability, HBRM's ROE is +0.04%, compared to JUSHF's ROE of +0.76%. Regarding short-term risk, HBRM is more volatile compared to JUSHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check JUSHF's competition here
HBRM vs ORXOY Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, ORXOY has a market cap of 98.4M. Regarding current trading prices, HBRM is priced at $0.00, while ORXOY trades at $2.80.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas ORXOY's P/E ratio is -2.24. In terms of profitability, HBRM's ROE is +0.04%, compared to ORXOY's ROE of +5.65%. Regarding short-term risk, HBRM is more volatile compared to ORXOY. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check ORXOY's competition here
HBRM vs CWBHF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, CWBHF has a market cap of 97.4M. Regarding current trading prices, HBRM is priced at $0.00, while CWBHF trades at $0.62.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas CWBHF's P/E ratio is -3.21. In terms of profitability, HBRM's ROE is +0.04%, compared to CWBHF's ROE of -2.75%. Regarding short-term risk, HBRM is more volatile compared to CWBHF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check CWBHF's competition here
HBRM vs MEDXF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, MEDXF has a market cap of 94.4M. Regarding current trading prices, HBRM is priced at $0.00, while MEDXF trades at $2.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas MEDXF's P/E ratio is -146.10. In terms of profitability, HBRM's ROE is +0.04%, compared to MEDXF's ROE of -0.01%. Regarding short-term risk, HBRM is more volatile compared to MEDXF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check MEDXF's competition here
HBRM vs ABSCF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, ABSCF has a market cap of 90.7M. Regarding current trading prices, HBRM is priced at $0.00, while ABSCF trades at $1.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas ABSCF's P/E ratio is -8.06. In terms of profitability, HBRM's ROE is +0.04%, compared to ABSCF's ROE of +0.33%. Regarding short-term risk, HBRM is less volatile compared to ABSCF. This indicates potentially lower risk in terms of short-term price fluctuations for HBRM.Check ABSCF's competition here
HBRM vs AAWH Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, AAWH has a market cap of 90M. Regarding current trading prices, HBRM is priced at $0.00, while AAWH trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas AAWH's P/E ratio is -0.73. In terms of profitability, HBRM's ROE is +0.04%, compared to AAWH's ROE of -14.10%. Regarding short-term risk, HBRM is more volatile compared to AAWH. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check AAWH's competition here
HBRM vs GRUSF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, GRUSF has a market cap of 83.9M. Regarding current trading prices, HBRM is priced at $0.00, while GRUSF trades at $0.34.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas GRUSF's P/E ratio is 33.58. In terms of profitability, HBRM's ROE is +0.04%, compared to GRUSF's ROE of +0.00%. Regarding short-term risk, HBRM is more volatile compared to GRUSF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check GRUSF's competition here
HBRM vs ORXOF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, ORXOF has a market cap of 80.3M. Regarding current trading prices, HBRM is priced at $0.00, while ORXOF trades at $2.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas ORXOF's P/E ratio is -1.83. In terms of profitability, HBRM's ROE is +0.04%, compared to ORXOF's ROE of +5.65%. Regarding short-term risk, HBRM is more volatile compared to ORXOF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check ORXOF's competition here
HBRM vs EOFBY Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, EOFBY has a market cap of 73.7M. Regarding current trading prices, HBRM is priced at $0.00, while EOFBY trades at $0.84.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas EOFBY's P/E ratio is -7.67. In terms of profitability, HBRM's ROE is +0.04%, compared to EOFBY's ROE of -0.77%. Regarding short-term risk, HBRM is more volatile compared to EOFBY. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check EOFBY's competition here
HBRM vs GDNSF Comparison April 2026
HBRM plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, HBRM stands at 1.1M. In comparison, GDNSF has a market cap of 61M. Regarding current trading prices, HBRM is priced at $0.00, while GDNSF trades at $0.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
HBRM currently has a P/E ratio of N/A, whereas GDNSF's P/E ratio is -2.66. In terms of profitability, HBRM's ROE is +0.04%, compared to GDNSF's ROE of -0.69%. Regarding short-term risk, HBRM is more volatile compared to GDNSF. This indicates potentially higher risk in terms of short-term price fluctuations for HBRM.Check GDNSF's competition here